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Caspases, the cysteine proteases that initiate and control apoptotic cell death,
are subject to allosteric regulation by a variety of modulators. Due to their
role in cell death, caspases are of interest as drug targets for diseases ranging
from cancer to neurodegeneration. The most significant hurdle to their thera-
peutic use appears to be related to the overlapping active-site specificities for
small molecule inhibitors, which do not fully reflect their true in vivo specific-
ities for protein substrates. Due to this complication, allosteric inhibition
of individual caspases or particular caspase sub-functions is of great interest.
Fortunately, caspases are extremely amenable to allosteric regulation, in large
part due to their remarkably plastic substrate-binding grooves, which can be
modulated by a number of distinct allosteric mechanisms. Our current work
is to develop a global map of the allosteric networks across the family. We
have discovered allosteric sites in caspase-6 and -9 that are natively regulated
by zinc and elucidated the molecular mechanism of inhibition crystallograph-
ically. We have identified other allosteric sites, unique to caspase-3, -6, -7, -8 or
-9 respectively, which are controlled by phosphorylation. The allosteric net-
works including these sites utilize distal control of the substrate-binding
groove. Based on our understanding of these mechanisms of inhibition, we
have engineered an allosterically handcuffed version of caspase-7 that can be
unlocked by the intracellular reduction potential. Finally, using specially-
designed nanoparticles we have delivered caspases and induced apoptosis in
cancer cells. Together these findings move us closer to a full understanding
of the allosteric networks controlling caspase function and therapeutically rele-
vant allosteric control of caspases.
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Protein phosphorylation is an essential regulatory mechanism that affects all
aspect of cellular life from division and growth to aging and death. Misregula-
tion of the signaling cascades leads to severe detrimental effects, and in humans
often associated with cancer and other diseases. Phosphorylation is performed
by a class of protein called kinases. Activation and deactivation of kinases is
normally under tight control and is regulated via different mechanisms that
are incredibly complex. In this work we combine phylogenetic resurrection
techniques with biophysical and chemical approaches to analyze the regulatory
mechanisms of modern tyrosine oncokinases Src and Abl, their common
ancestor and the common ancestors between several other families of tyrosin
kinases. Our results show how the regulatory elements appeared and developed
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The receptor tyrosine kinases (RTKs) are amajor class of transmembrane recep-
tors responsible for regulation of many biological processes, including develop-
ment andmaintenance of synapses. Many RTKs act in concert with intracellular
proteins which are thought to interact with cell membranes. Downstream-of-
Kinase 7 (Dok7) is a soluble protein involved in the Muscle-Specific Kinase
(MuSK) signalling pathway. Dok7 binds to MuSK to facilitate clustering of
acetylcholine receptors at synapses. Mutations in Dok7 have been known to
result in varying degrees of severity of congential myasthenic syndromes, which
is characterised by impaired muscle contractions. The structure of Dok7 reveals
it to contain a pleckstrin-homology (PH) and a phosphotyrosine-binding (PTB)
domain.Although there is evidence to suggest howDok7 interactswithMuSK, it
is unknown exactly how it interacts with the cell membrane.
Here we apply a multi-scale Molecular Dynamics simulations method to char-
acterise Dok7’s interactions with membranes of varying lipid composition.
Coarse-grained (CG) simulations are used to characterise the mechanism ofwhich Dok7 binds to the bilayer, while atomistic simulations are used to refine
its interactions with specific lipids present in the bilayer. These computational
studies reveal the role of phosphatidylinositol phosphates (PIP) in the interac-
tion of Dok7 with complex cell membranes.
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ADP-ribosylation factor-like (Arl) proteins are small GTPases, with Arl2 and
Arl3 being close homologues that share almost all their interacting partners.
Despite all similarities, Arl2 and Arl3 have distinct biological functions:
Arl3 is regarded as a ciliary protein, whereas Arl2 has been reported to be
involved in tubulin folding and Ras signaling. Defective ciliary function results
in a number of human diseases. So far, how are these different roles attained by
the two homologue proteins is not a fully answered question.
A recent study showed that theN-terminal amphipathic helix ofArl3 but notArl2
can function as a GTP-dependent pocket opener, displacingmyristoylated cargo
from the lipid-binding pocket of the GDI-like solubilizing factor UNC119a/b
[1]. This would imply that membrane-bound Arl3GTP is not able to bind
UNC119a/b, since this helix is predicted to mediate Arl3 membrane binding
and is only exposed in Arl3GTP, thus connecting the membrane binding capac-
ity of Arl to its nucleotide status and the availability of the N-terminal helix.
In the present study, the membrane binding behavior of Arl3, Arl2, and
UNC119a has been investigated by surface plasmon resonance, atomic force
microscopy, and infrared reflection absorption spectroscopy to gain insight
into the role of the N-terminal amphipathic helix of Arl2/3 during membrane
binding and its modulation by complexation with UNC119a. The data reveal
a preferential localization of Arl2/3 in the liquid-disordered phase of heteroge-
neous model membranes. Unlike Arl3 and other Arf proteins, Arl2 binds to
membranes in a nucleotide-independent manner. Finally, UNC119a selectively
impedes membrane binding of Arl3GTP.
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Ras is a small GTP-binding protein and involved in a variety of cellular pro-
cesses. The isoform K-Ras4B binds with its polybasic farnesylated C-terminus
to membranes and can enter multiple interactions with a wide variety of effec-
tors. PDEd and calmodulin (CaM) are known to function as potential binding
partners for farnesylated Ras proteins, leading to a modulation of the dynamics
of Ras membrane association. A previous study of our group showed that PDEd
is not able to extract K-Ras4B from model raft membranes; instead, an effec-
tive delivery of PDEd-solubilized K-Ras4B to the plasma membrane was pro-
posed [1]. Since CaM exhibits additional interaction sites to the G-domain of
K-Ras4B as compared to PDEd and was shown not to be required for the trans-
port of K-Ras4B to the plasma membrane, it was suggested that calmodulin dis-
sociates K-Ras4B from membranes [2]. In the present biophysical approach,
the influence of CaM on the interaction of K-Ras4B with anionic model raft
membranes has been investigated by surface plasmon resonance, atomic force
microscopy and fluorescence anisotropy measurements, supplemented by
infrared reflection absorption spectroscopy experiments. The results suggest
a repulsion of the K-Ras4B/CaM complex from the membrane. At the end,
differentiation between the function of the two farnesyl-binding proteins on
K-Ras4B is envisaged.
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